Eiletoclax

N/A

Report date: 2024/02/04 11:53:14
NME

Base Information

Drug NameEiletoclax
Drug Alias NameZE50-0134ZE-500134
ClassificationSmall molecules
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLymphoma +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A